Australian institute for infectious disease

The Victorian Government is committed to the development of the new Australian Institute for Infectious Disease (AIID) in Victoria.

The new facility will protect Australians against future infectious diseases and pandemics.

Building on $155 million in funding announced in 2020, the Victorian Government will deliver up to an additional $245 million to get the project off the ground and build the Institute. It will be located in the heart of the Melbourne Biomedical  Precinct.

The $650 million project will also be supported with $250 million from the Foundation Partners – the University of  Melbourne, the Doherty Institute for Infection and  Immunity and the Burnet  Institute.

The COVID-19 pandemic highlighted the importance of getting ahead of outbreaks. This Institute is designed to deliver the infrastructure and capacity that researchers need to detect, analyse, manage and develop treatments for infectious diseases.

The Institute will be the largest centre of expertise in the Southern Hemisphere. It will supercharge the ongoing efforts of the world-leading researchers at Victoria’s universities and medical research institutes. It will also accelerate research into the prevention of future pandemics.

The AIID will enable the Doherty Institute to expand and the Burnet Institute to relocate to the Melbourne Biomedical Precinct.

In addition, it will bring together experts from the Walter and Eliza Hall Institute for Medical  Research, the Murdoch Children’s Research  Institute and Melbourne-headquartered global biotechnology company CSL, to ensure Victoria and Australia are prepared for future challenges.

The Institute will include next-generation laboratories and high-containment facilities that will help researchers improve our understanding of infectious diseases. A robotic biobank facility will ensure international best practice for specimen storage in large-scale clinical trials.

Visit the AIID  website or watch these videos to learn more

Page last updated: 18 November 2024